Iridex (IRIX) EBITDA Margin Growth (3y) (2013 - 2026)
Iridex (IRIX) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.26 Bn | 176.96 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 47.53 Bn | 43.86 Bn | 1.29 Bn | -283.00 |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -184.00 |
| 7 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | 1,505.00 |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.41 Bn | 2.07 Bn | -763.00 |
| 10 | Iridex | 15.20 Mn | 10.60 Mn | 4.74 Mn | 1,436.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 1,436.00 |
| Jan 3, 2026 | 918.00 |
| Sep 27, 2025 | 28.00 |
| Jun 28, 2025 | 878.00 |
| Mar 29, 2025 | 1,529.00 |
| Dec 28, 2024 | 23.00 |
| Sep 28, 2024 | 11.00 |
| Jun 29, 2024 | -1,241.00 |
| Mar 30, 2024 | -1,261.00 |
| Sep 30, 2023 | 783.00 |
| Jul 1, 2023 | 2,225.00 |
| Apr 1, 2023 | 122.00 |
| Dec 31, 2022 | 447.00 |
| Oct 1, 2022 | 579.00 |
| Jul 2, 2022 | 797.00 |
| Apr 2, 2022 | 1,165.00 |
| Jan 1, 2022 | 2,118.00 |
| Oct 2, 2021 | 1,077.00 |
| Jul 3, 2021 | 2,338.00 |
| Apr 3, 2021 | 2,264.00 |